Back to top
Top

Intensive Care Unit Venous Thromboembolism Prophylaxis

Specifications
Attachment Size
CMS190v9.html 109.7 KB
CMS190v9.zip 127.1 KB
CMS190v9-TRN.xlsx 23.01 KB
CMS Measure ID
CMS190v9
Version
9
NQF Number
Not Applicable
Measure Description

This measure assesses the number of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after the initial admission (or transfer) to the Intensive Care Unit (ICU) or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer)

Initial Population

Inpatient hospitalizations for patients age 18 and older, discharged from hospital inpatient acute care without a diagnosis of venous thromboembolism (VTE) or obstetrics with a length of stay less than or equal to 120 days that ends during the measurement period

Denominator Statement

Inpatient hospitalizations for patients directly admitted or transferred to ICU during the hospitalization

Denominator Exclusions

* Inpatient hospitalizations for patients who have a hospital length of stay (LOS) less than 2 days

* Inpatient hospitalizations for patients with comfort measures documented anytime between the day of arrival and the day after ICU admission or transfer

* Inpatient hospitalizations for patients with comfort measures documented by the day after surgery end date for surgeries that end the day of or the day after hospital admission

* Inpatient hospitalizations for patients with a principal procedure of surgical care improvement Project (SCIP) VTE selected surgeries that end the day of or the day after ICU admission or transfer

Numerator Statement

Inpatient hospitalizations for patients who received VTE prophylaxis:

- the day of or the day after ICU admission (or transfer)

- the day of or the day after surgery end date for surgeries that end the day of or the day after ICU admission (or transfer)

Inpatient hospitalizations for patients who have documentation of a reason why no VTE prophylaxis was given:

- between the day of arrival and the day after ICU admission (for patients directly admitted as inpatients to the ICU)

- the day of or the day after surgery end date (for surgeries that end the day of or the day after ICU admission (or transfer)

Numerator Exclusions

Not Applicable

Denominator Exceptions

Inpatient hospitalizations for patients with ICU LOS less than one day

Measure Steward
Short Name
VTE-2
Previous Version
Measure Scoring
Measure Type
Improvement Notation

Improvement noted as an increase in rate

Guidance

The definition of an ICU for the purpose of the measures noted above is that used by the CDC in the NHSN Patient Safety Project. An intensive care unit can be defined as a nursing care area that provides intensive observation, diagnosis, and therapeutic procedures for adults and/or children who are critically ill. An ICU excludes nursing areas that provide step-down, intermediate care or telemetry only and specialty care areas.

Reasons for no pharmacological and no mechanical VTE prophylaxis must be explicitly documented by the MD/APN/PA or pharmacist and linked with VTE prophylaxis. Ambulation alone is not a sufficient reason for not administering VTE prophylaxis. In order for ambulation/patient ambulating to be considered as an acceptable reason, there needs to be explicit documentation, e.g., "patient out of bed and ambulating in halls - no VTE prophylaxis needed."

This eCQM is an episode-based measure.

This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM.

Meaningful Measure
Release Notes

Header

  • Updated eCQM Version Number.

    Measure Section: eCQM Version Number

    Source of Change: Standards Update

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated references.

    Measure Section: Reference

    Source of Change: Measure Lead

  • Added text to identify the Quality Data Model (QDM) version used in the measure specification.

    Measure Section: Guidance

    Source of Change: Standards Update

  • Added text to indicate whether the measure is patient-based or episode-based.

    Measure Section: Guidance

    Source of Change: Standards Update

Logic

  • QDM v5.5 standards update: Replaced 'Assessment, Performed' attribute 'authorDatetime' with 'relevantDatetime' and added a new variable in various logic locations.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Renamed the ​'In Low Risk for VTE or On Anticoagulant' definition and revise logic for clarification consistent with the Clinical Quality Language (CQL) Style Guide.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Added 'Rivaroxaban and Betroxban for VTE Prophylaxis' to definitions due to US Food and Drug Administration (FDA) approval of Rivaroxaban and Betrixaban for VTE prophylaxis.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Followed CQL Style Guide to be consistent when defining surgical care improvement project (SCIP) acronym.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Removed function VTEICU.FirstInpatientIntensiveCareUnit() to use existing Global Common Library function Global.FirstInpatientIntensiveCareUnit().

    Measure Section: Functions

    Source of Change: Measure Lead

  • CQL Library version update: Updated version number of the TJC_Overall Library (TJC_Overall-4.4.000).

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

  • CQL Library version update: Updated version number of the VTEICU Library (VTEICU-4.0.000).

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

  • QDM v5.5 standards update: Modified 'Encounter, Performed' diagnosis attribute to reference diagnosis codes in value sets specified in the logic.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • QDM v5.5 standards update: Added 'relevantDatetime' attribute to QDM datatypes. 'RelevantDatetime' indicates when the action occurred whereas 'authorDatetime' indicates when the action was recorded.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Updated CQL expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 4 (CQL 1.4).

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Updated the names of CQL definitions, functions, and/or aliases for clarification and to align with the CQL Style Guide.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Updated version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-5.0.000).

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Updated definitions and functions in the MAT Global Common Functions Library to align with standards changes, CQL Style Guide, and to include one new function related to calculating length of hospital stays with observation stays.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Low Dose Unfractionated Heparin for VTE Prophylaxis (2.16.840.1.113762.1.4.1045.39): Added 1 RxNorm code (2121591) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Atrial Fibrillation/Flutter Value Set (2.16.840.1.113883.3.117.1.7.1.202): Removed 2 ICD-10-CM codes (I48.1, I48.2) and added 4 ICD-10-CM codes (I48.11, I48.19, I48.20, I48.21) based on terminology update.

    Measure Section: Terminology

    Source of Change: ONC Project Tracking System (Jira): CQM-3827

  • Value set Unfractionated Heparin (2.16.840.1.113883.3.117.1.7.1.218): Deleted 1 RxNorm code (1658720) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set General Surgery (2.16.840.1.113883.3.117.1.7.1.255): Added 2 SNOMED CT codes (47208000, 81561002) and deleted 7 SNOMED CT codes (14037006, 274029004, 275016006, 277578005, 426267007, 87389009, 89646009) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Gynecological Surgery (2.16.840.1.113883.3.117.1.7.1.257): Added 1 SNOMED CT code (784191009) and deleted 1 SNOMED CT code (236890000) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Intracranial Neurosurgery (2.16.840.1.113883.3.117.1.7.1.260): Deleted 1 SNOMED CT code (230892001) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Venous Thromboembolism (2.16.840.1.113883.3.117.1.7.1.279): Added 3 ICD-10-CM codes (I26.93, I26.94, I28.9) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Hip Replacement Surgery (2.16.840.1.113883.3.117.1.7.1.259): Deleted 3 SNOMED CT codes (29969002, 33788003, 425443008) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Knee Replacement Surgery (2.16.840.1.113883.3.117.1.7.1.261): Added 1 SNOMED CT code (609588000) and deleted 3 SNOMED CT codes (430698003, 443543000, 443658004) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Obstetrics (2.16.840.1.113883.3.117.1.7.1.263): Added 17 SNOMED CT codes and deleted 27 SNOMED CT codes based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Observation Services (2.16.840.1.113762.1.4.1111.143): Deleted 2 SNOMED CT codes (448851000124103, 76464004) based on clinical/coding expert feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Rivaroxaban and Betrixaban for VTE Prophylaxis (2.16.840.1.113762.1.4.1110.50): Added Rivaroxaban and Betrixaban for VTE Prophylaxis due to FDA approval of Rivaroxaban and Betrixaban for VTE prophylaxis.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Principal (2.16.840.1.113883.3.117.1.7.1.14): Removed Principal due to QDM v5.5 standards updates.

    Measure Section: Terminology

    Source of Change: Standards Update

Last Updated: May 18, 2020